EUVIMEDEUVIMED entdecken
Fallbericht

Etoricoxib-Induced Fixed Drug Eruption with Cutaneous and Mucosal Involvement: A Case Report

Luz M. Moyano Vidal, Lucia M. Bolivar-Herrada, Martha Patricia Diaz Guevara

Revista Cientifica Internacional de Ciencias de la Salud · 31.03.2026 · 3 (1) · 67-72

DOI: 10.57188/ricsa.2026.010 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Revista Cientifica Internacional de Ciencias de la Salud, online erschienen am 31.03.2026. Verfasst von Luz M. Moyano Vidal und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Fixed drug eruption (FDE) is a delayed hypersensitivity reaction characterized by erythematous- violaceous plaques recurring at identical anatomical sites upon re-exposure to the causative drug, with persistent residual hyperpigmentation. Etoricoxib, a widely used COX-2 inhibitor, is an increasingly recognized trigger. Case Report: A 49-year-old woman developed hyperpigmented plaques on the arms and oral mucosa eight hours after a single dose of etoricoxib 120 mg for acute low back pain. A clinically identical episode had occurred two years earlier at the same sites, initially misdiagnosed as herpetic infection. Diagnosis was established by temporal chronology, exact anatomical recurrence, and a Naranjo score of 10 (definite causal relationship). Management comprised drug discontinuation, oral antihistamine, and topical corticosteroid, with favorable outpatient evolution.

Conclusion

This case illustrates etoricoxib-induced FDE with cutaneous and mucosal involvement and exact site recurrence. Early recognition, definitive discontinuation, and pharmacovigilance reporting are clinical imperatives to prevent recurrence and ensure safe alternatives.

Zitieren

APA

Vidal, L. M. M., Bolivar-Herrada, L. M., & Guevara, M. P. D. (2026). Etoricoxib-Induced Fixed Drug Eruption with Cutaneous and Mucosal Involvement: A Case Report. Revista Cientifica Internacional de Ciencias de la Salud, 3(1), 67-72. https://doi.org/10.57188/ricsa.2026.010

Vancouver

Vidal LMM, Bolivar-Herrada LM, Guevara MPD. Etoricoxib-Induced Fixed Drug Eruption with Cutaneous and Mucosal Involvement: A Case Report. Revista Cientifica Internacional de Ciencias de la Salud. 2026;3(1):67-72. doi:10.57188/ricsa.2026.010

BibTeX
@article{Vidal2026,
  author = {Vidal, Luz M. Moyano and Bolivar-Herrada, Lucia M. and Guevara, Martha Patricia Diaz},
  title = {Etoricoxib-Induced Fixed Drug Eruption with Cutaneous and Mucosal Involvement: A Case Report},
  journal = {Revista Cientifica Internacional de Ciencias de la Salud},
  year = {2026},
  volume = {3},
  number = {1},
  pages = {67--72},
  doi = {10.57188/ricsa.2026.010}
}
Kostenlos starten →